Evidence map›Paper›PMID 40628921›Full record

ArticleScientific reports2025

High-resolution fecal pharmacokinetic modeling in mice with orally administered antibiotics.

Rie Maskawa, Lena Takayasu, Hideki Takayasu, Keiji Watanabe, Shusuke Takemine, Takashi Kakimoto, Kozue Takeshita, Seiko Narushima, Wataru Suda, Misako Takayasu

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rie MaskawaSchool of Computing, Institute of Science Tokyo, Yokohama, Kanagawa, Japan.
Lena TakayasuMeinig School of Biomedical Engineering, Cornell University, Ithaca, New York, USA.
Hideki TakayasuSchool of Computing, Institute of Science Tokyo, Yokohama, Kanagawa, Japan.
Keiji WatanabeCenter for Environmental Science in Saitama, Kazo, Saitama, Japan.
Shusuke TakemineCenter for Environmental Science in Saitama, Kazo, Saitama, Japan.
Takashi KakimotoCenter for Environmental Science in Saitama, Kazo, Saitama, Japan.
Kozue TakeshitaDepartment of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.
Seiko NarushimaCenter for Integrative Medical Sciences, RIKEN, Yokohama, Kanagawa, Japan.
Wataru SudaCenter for Integrative Medical Sciences, RIKEN, Yokohama, Kanagawa, Japan.
Misako TakayasuSchool of Computing, Institute of Science Tokyo, Yokohama, Kanagawa, Japan. takayasu@comp.isct.ac.jp.

Funding

Japan Agency for Medical Research and Development 23ae0121046Japan Science and Technology Agency JPMJCR22N3Japan Society for the Promotion of Science 24KJ1073
6 · The paper itself

Abstract

High-resolution fecal pharmacokinetics are crucial for optimizing therapeutic design and evaluating gastrointestinal motility. However, empirical studies with detailed fecal concentration over time data remain limited. This study aims to characterize fecal pharmacokinetics through high-frequency sampling and parallelized fecal concentration quantification, establishing a simple pharmacokinetics model with physiologically interpretable parameters. We quantified vancomycin concentrations in fecal samples collected at a minimum interval of 4 hours from C57BL/6N mice following a single oral administration of either a low (1 mg/mL) or high (20 mg/mL) dose. Fecal concentrations gradually increased and exhibited an exponential decay, leading to the development of a compartmental model with an absorption phase. This simple model accurately fit the experimental data and provided physiological explanations for intra- and inter-individual pharmacokinetics variability. The results suggest that inter-individual differences in pharmacokinetics are attributable to fecal elimination capacity, which may be influenced by drug dosage via changes in gastrointestinal motility. Since the model predicts antibiotic concentrations within the gastrointestinal tract, it can be applied to fundamental studies investigating the effects of antibiotics on the gut microbiome and gastrointestinal motility.

Indexed as

Anti-Bacterial AgentsFecesModels, BiologicalVancomycinAdministration, OralAnimalsGastrointestinal MicrobiomeGastrointestinal MotilityMaleMiceMice, Inbred C57BLAnti-Bacterial AgentsVancomycinAntibioticsCompartment modelPharmacokineticsSolid phase extraction

Identifiers

PMID40628921
PMCPMC12238578

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.